Skip to content

Advances in Motion

Medical Grand Rounds: Not Throwing Away Our Shot: Scaling Up COVID-19 Vaccination Efforts in the U.S.

Article

In This Article

  • On February 4, 2021, the Department of Medicine at Massachusetts General Hospital co-hosted a virtual Grand Rounds presentation related to COVID-19 with Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center
  • Joshua P. Metlay, MD, PhD, chief of the Division of General Internal Medicine at Massachusetts General Hospital, and Bisola Ojikutu, MD, MPH, Division of Infectious Diseases at Mass General, spoke with the Boston medical community on scaling up COVID-19 vaccination efforts in the United States

On February 4, 2021, the Department of Medicine at Massachusetts General Hospital held a virtual Grand Rounds on COVID-19. Mass General's Joshua P. Metlay, MD, PhD, chief of the Division of General Internal Medicine, and Bisola Ojikutu, MD, MPH, of the Division of Infectious Diseases, Brigham and Women’s Hospital and Mass General and Division of Global Health Equity at Brigham and Women’s Hospital, spoke with the Boston medical community on scaling up COVID-19 vaccination efforts in the United States.

The session was moderated by Katrina Armstong, MD, physician-in-chief in the Department of Medicine at Mass General. Other speakers included Dhruv S. Kazi, MD, MSc, MS, associate director, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology and director, Cardiac Critical Care Unit at Beth Israel Deaconess Medical Center, and Ai-Ris Y. Collier, MD, Division of Maternal Fetal Medicine at Beth Israel Deaconess Medical Center.

Watch the video »

View all COVID-19 updates

Learn about COVID-19 Grand Rounds at Mass General

Related topics

Related

In this Q&A, Kimberly Blumenthal, MD, MSc, explains what may cause an allergic reaction to the vaccine, what makes someone higher risk for an adverse event, and what doctors can do to help patients understand and manage the risk.

Allergy, COVID-19, Research and Innovation, Rheumatology, Allergy and Immunology, Vaccine

Article

Related

Rochelle P. Walensky, MD, MPH, former chief of the Division of Infectious Diseases, and colleagues demonstrate in a mathematical model that the benefits of any COVID-19 vaccine will depend as much on how fast and broadly it's implemented and the severity of the epidemic as on the vaccine's efficacy in clinical trials.

COVID-19, Research and Innovation, Vaccine

Journal